Infinity Pharmaceuticals Inc
OTC:INFIQ

Watchlist Manager
Infinity Pharmaceuticals Inc Logo
Infinity Pharmaceuticals Inc
OTC:INFIQ
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: 91 USD
Have any thoughts about
Infinity Pharmaceuticals Inc?
Write Note

Infinity Pharmaceuticals Inc
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Infinity Pharmaceuticals Inc
Cash & Cash Equivalents Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Infinity Pharmaceuticals Inc
OTC:INFIQ
Cash & Cash Equivalents
$17.7m
CAGR 3-Years
-15%
CAGR 5-Years
-18%
CAGR 10-Years
-11%
Abbvie Inc
NYSE:ABBV
Cash & Cash Equivalents
$13.1B
CAGR 3-Years
15%
CAGR 5-Years
20%
CAGR 10-Years
4%
Gilead Sciences Inc
NASDAQ:GILD
Cash & Cash Equivalents
$2.8B
CAGR 3-Years
-17%
CAGR 5-Years
-24%
CAGR 10-Years
-11%
Amgen Inc
NASDAQ:AMGN
Cash & Cash Equivalents
$9.3B
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
8%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash & Cash Equivalents
$4.6B
CAGR 3-Years
-9%
CAGR 5-Years
7%
CAGR 10-Years
27%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash & Cash Equivalents
$1.9B
CAGR 3-Years
-2%
CAGR 5-Years
13%
CAGR 10-Years
12%

See Also

What is Infinity Pharmaceuticals Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
17.7m USD

Based on the financial report for Jun 30, 2023, Infinity Pharmaceuticals Inc's Cash & Cash Equivalents amounts to 17.7m USD.

What is Infinity Pharmaceuticals Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
-11%

Over the last year, the Cash & Cash Equivalents growth was -61%. The average annual Cash & Cash Equivalents growth rates for Infinity Pharmaceuticals Inc have been -15% over the past three years , -18% over the past five years , and -11% over the past ten years .

Back to Top